FEATURE


showcases


future of IR W


ith daily presentations of impactful research and a wide range of hands-on learning


opportunities, advanced products from industry throughout the Expo, and spotlights on how the society is working with other specialties and IR associations around the world, the SIR 2016 Annual Scientific Meeting in Vancouver offered attendees a thorough look at the state of IR today and tomorrow in the majestic setting of Vancouver, British Columbia.


The society thanks the Annual Scientific Committee, faculty, volunteers, corporate supporters, attendees and all else who made the meeting such a historic success.


Among the studies presented at the meeting were the following research highlights:


• Bariatric arterial embolization has been shown to sustain weight loss in morbidly obese individuals, creating an additional treatment option to control their body weight.


20 IR QUARTERLY | SPRING 2016


• Image-guided percutaneous nerve cryoablation may represent an effective new therapy for patients with phantom pains related to limb loss.


• A smart phone app can guide needle placement, resulting in an average margin of error of 1.5 degrees or less.


• At one year post embolization, UFE significantly improves quality of life and all areas of sexual function.


• Y-90 radioembolization for patients with unresectable HCC resulted in significantly longer time-to- progression when compared to conventional transarterial chemoembolization.


• Prostatic artery embolization has been shown to reduce nocturia in men with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms.


The hands-on workshop program featured 80 different workshops covering more than 50 distinct topics. The nearly 60 case-based workshops covered a wide variety of


interventional oncology topics and peripheral arterial disease topics, as well as a host of other IR-specific topics, including legal issues and coding and billing.


Attendees had multiple opportunities to interact with some of their interdisciplinary colleagues during special “SIR Meets” sessions, which included representatives from other specialty societies who joined SIR members in discussing important topics in vascular medicine, clinical oncology, venous disease, urology and podiatry.


To address the resurgence of interest in stroke treatment, the SIR Stroke Course offered in-depth didactic lectures, panel discussions and case scenarios emphasizing current concepts in patient selection and endovascular stroke therapy.


A diversity and inclusion roundtable discussion addressed low ethnic and gender diversity in IR as compared to the overall populations as well as to other specialties. Panelists discussed


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40